Hepatitis B surface antigen (HBsAg) prevalence (%) in Kenya
Kenya: Hepatitis B surface antigen (HBsAg) prevalence was 0.7% in 2024. ▼ Falling
Latest (2024)
0.7%
Change on year
down 12.5%
World rank
43rd
of 194 countries
All-time high
1.1%
in 2017
All-time low
0.7%
in 2024
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Kenya, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Kenya recorded 0.7% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
The figure is down 12.5% on the previous year and down 30.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Kenya peaked at 1.1% in 2017 and was at its lowest, 0.7%, in 2024.
That places Kenya 43rd out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Kenya, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.0% | — |
| 2016 | 1.0% | +0.0% |
| 2017 | 1.1% | +10.0% |
| 2018 | 1.1% | +0.0% |
| 2019 | 1.1% | +0.0% |
| 2020 | 1.0% | -9.1% |
| 2021 | 1.0% | +0.0% |
| 2022 | 0.9% | -10.0% |
| 2023 | 0.8% | -11.1% |
| 2024 | 0.7% | -12.5% |
Kenya compared with similar countries
- Kenya's 0.7% is above the median for lower middle income countries, which is 0.6%, 1.2× the median. (47 countries reporting)
- Kenya's 0.7% is below the median for Sub-Saharan Africa, which is 1.1%, 67% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.1% | 1.0% | 1.1% | 5 |
| 2020s | 0.9% | 0.7% | 1.0% | 5 |
Countries ranked near Kenya
- 43 Sierra Leone 0.7% compare
- 43 Benin 0.7% compare
- 43 Burkina Faso 0.7% compare
- 43 Brunei 0.7% compare
- 43 Cape Verde 0.7% compare
- 43 Indonesia 0.7% compare
- 43 Liberia 0.7% compare
More health data for Kenya
- Un projection of annual infant deaths, annual growth rate -1.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6026 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,119 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,059 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 89 (2025)
- Population ages 00-04, female, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0621 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Kenya?
- Hepatitis b surface antigen (hbsag) prevalence in Kenya was 0.7% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Kenya?
- The highest recorded value was 1.1% in 2017.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Kenya?
- The lowest recorded value was 0.7% in 2024.
- How does Kenya rank for hepatitis b surface antigen (hbsag) prevalence?
- Kenya ranks 43rd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Kenya?
- Over the last ten years it is down 30.0%. The long-run trend across the full record is falling.
- Where does this Kenya data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).